Revolution Medicines is a clinical-stage pharma company with a market cap of ~6 billion. Click here to find out why RVMD ...

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) hit a new 52-week low during mid-day trading on Saturday . The stock traded as low as $30.94 and last traded at $31.32, with a volume of ...

Highlights,Institutional stakeholders adjusted positions during the fourth quarter, including new entries and reductions.,Executive leadership conducted partial equity sales, contributing to minor ...

Most analysts love Revolution Medicines, which has an average rating of buy. But there's reason to believe the stock may be ...

Stifel analyst Benjamin Burnett lowered the firm’s price target on Revolution Medicines (RVMD) to $64 from $78 and keeps a Buy rating on the ...

We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look ...

To listen to a live webcast of any of these events, or access archived webcasts, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcasts, replays will be available on ...

Quantbot Technologies LP bought a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) during the ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s ‘Power Lunch’ to discuss investing in ...

Revolution Medicines, Inc. (NASDAQ:RVMD) is a clinical-stage precision oncology company that develops novel targeted therapies. It discovers and develops cancer treatments through novel ...